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Abstract The inflammatory response following spinal cord
injury (SCI) involves the activation of resident microglia and
the infiltration of macrophages. Macrophages and microglia
can be polarized into the classically activated proinflammato-
ry M1 phenotype or the alternatively activated anti-
inflammatory M2 phenotype. Programmed cell death 1 (PD-
1) is a critical immune inhibitory receptor involved in innate
and adaptive immune responses. However, whether PD-1 is
involved in the modulation of macrophage/microglial polari-
zation is unknown. In this study, the mRNA levels of pd1
gradually increased after SCI, and PD-1 protein was found in
macrophages/microglia in injured spinal cord sections. PD-1
knockout (KO) mice showed poor locomotor recovery after
spinal cord crushing compared with wild-type mice. M1-type
macrophages/microglia accumulated in greater numbers in the
injured spinal cord of PD-1-KO mice. Under polarized stim-
ulation, induced expression of PD-1 occurred in cultured
macrophages and microglia. PD-1 suppressed M1 polariza-
tion by reducing the phosphorylation of signal transducer and
activator of transcription 1 (STAT1) and promoted M2
polarization by increasing STAT6 phosphorylation. In PD-1-
KOmice, the M1 response was enhanced via the activation of
STAT1 and nuclear factor-kappa B. Furthermore, PD-1 played
various roles in phagocytosis in macrophages and microglia.
Therefore, our results suggest that PD-1 signaling plays an
important role in the regulation of macrophage/microglial
polarization. Thus, deregulated PD-1 signaling may induce
the polarization of macrophages/microglia toward the M1
phenotype. Overall, our results provide new insights into the
modulatory mechanisms of macrophage/microglial polariza-
tion, thereby possibly facilitating the development of new
therapies for SCI via the regulation of macrophage/
microglial polarization through PD-1 signaling.
Keywords Macrophage .Microglia . Polarization .
Programmed death 1 . Spinal cord injury
Introduction
The inflammatory response plays an important role in the
pathogenesis of spinal cord injury (SCI) [1, 2].
Macrophages/microglia are the predominant inflammatory
cells responsible for this response, and can be polarized into
the “classically activated”M1 phenotype or the “alternatively
activated”M2 phenotype depending on the signals within the
lesion microenvironment [3]. Under in vitro conditions, expo-
sure to lipopolysaccharide (LPS) and interferon gamma
(IFN-γ) activates M1 macrophages, whereas the presence of
interleukin 4 (IL-4) or IL-13 activates the M2 phenotype [4].
M1 macrophages/microglia produce high levels of proinflam-
matory cytokines, such as IL-12, IL-1β, and tumor necrosis
factor alpha, in addition to increased levels of oxidative me-
tabolites, such as inducible nitric oxide synthase (iNOS) [5, 6].
These inflammatory factors are promoted by the IFN-γ-
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mediated signal transducer and activator of transcription 1
(STAT1) signaling pathway. In contrast, M2 macrophages
produce high levels of arginase 1 (Arg1), mannose receptor
(CD206), IL-10, transforming growth factor beta (TGF-β),
and several neurotrophic factors, such as ciliary neurotrophic
factor, insulin-like growth factor, epidermal growth factor, and
nerve growth factor, all of which suppress inflammatory re-
sponses and facilitate axonal regeneration. These molecules
are mediated by the STAT6 signaling pathway [3]. In SCI, 2
distinct macrophage/microglia subsets (M1 or M2) with op-
posing effects (neurotoxicity or regeneration) have been iden-
tified based on their ratio during pathological processes [7]. In
the first few days after SCI, macrophages/microglia upregu-
late the levels of iNOS and proinflammatory cytokines
(TNF-α, IL-1β, and IL-6), which polarize and maintain these
cells toward the M1 phenotype [8, 9]. Kigerl et al. [7] reported
that M1 macrophages/microglia are maintained in lesion sites
weeks after injury in the contused mouse spinal cord; howev-
er, the number ofM1 cells is markedly reduced 14 and 28 days
after SCI. Furthermore, inhibitory signals may prevent the
overactivation of M1 macrophages/microglia after SCI
[10–12].
Programmed death 1 (PD-1 or CD279) is a 288-amino acid
type-I transmembrane protein that belongs to the CD28 su-
perfamily and shares 23 % amino acid sequence homology
with cytotoxic T-lymphocyte-associated antigen 4 [11, 12]. As
a co-inhibitory receptor, PD-1 and its ligands—PD-L1 (B7-
H1; CD274) and PD-L2 (B7-DC; CD273)—elicit inhibitory
signals that regulate the balance between T-cell activation,
tolerance, and immune-mediated tissue damage [11, 12].
The expression of PD-1 on T cells, natural killer cells, B cells,
and monocytes is induced upon activation; thus, PD-1 plays
critical roles in the regulation of autoimmunity, tumor immu-
nity, viral/parasite immunity, the innate inflammatory re-
sponse, and allergy, and in immune privilege [11–13]. The
binding of PD-L1 to PD-1 recruits src homology region 2
domain-containing phosphatase 2 (SHP-2) or SHP-1/SHP-2
with the cytoplasmic domain immunoreceptor tyrosine-based
inhibitory motif (ITIM) and immunoreceptor tyrosine-based
switch motif, both of which inhibit proliferation and cytokine
production in T lymphocytes [11]. Although the role of PD-1
in the adaptive immune system has been well characterized
[10–12], its function in the innate immune system has only
recently been investigated. Several studies have revealed a
possible role for PD-1 in macrophages [13–17]; however,
whether PD-1 is involved in the regulation of the polarization
of macrophages is still unknown. In this study, we show that
PD-1 deficiency promotes M1 polarization of macrophages/
microglia and exacerbates locomotor recovery after SCI. We
also demonstrate that PD-1 deficiency in vitro regulates the
M1/M2 polarization of macrophages/microglia via STAT1 or
STAT6 phosphorylation, thereby playing opposing roles for
phagocytosis in macrophages and microglia.
Materials and Methods
Animals
PD-1 knockout (KO) (Pdcd-1-/-) male mice (a gift from Dr.
Tasuku Honjo, Kyoto University, Japan) were produced on a
C57BL/6 background. Wild-type (WT) male C57BL/6 mice
were purchased from Shanghai Laboratory Animal Center
(Shanghai, China). All experiments were performed in accor-
dance with the guidelines established by the Animal Care and
Use Committee of Fourth Military Medical University (Xian,
China).
SCI Model
Mice received a severe midthoracic (T8–T9) crush injury
using Dumont type forceps with a spacer of 0.2 mm, as
described previously [18]. Briefly, laminectomy of vertebrae
T8–T9 was performed using a pair of fine rongeurs, and care
was taken not to damage the dura. For eachmouse, the forceps
were used to laterally compress the spinal cord at a depth of
0.2 mm for 20 s. After surgery, each mouse was housed
separately, and manual bladder expression was performed
twice a day. Sham-operated mice received laminectomy with-
out crush injury.
Bone Marrow-Derived Macrophages and Drug Treatment
Bone marrow-derived macrophages (BMDMs) were generat-
ed, as described previously [19]. Briefly, bone marrow cells
from the femurs and tibias of mice were triturated (using 26-
gauge needles) in RPMI 1640 medium containing 10 % fetal
bovine serum (FBS; Gibco, Carlsbad, CA, USA). Red blood
cells were lysed in lysis buffer (0.15 M NH4Cl, 10 nM
KHCO3, and 0.1 mM Na2 ethylenediaminetetraacetic acid,
pH7.4), washed once in RPMI 1640 with 10 % FBS, and then
plated in RPMI 1640 supplemented with 1 % penicillin/
streptomycin, 1 % 4-(2-hydroxyethyl) piperazine-1-
ethanesulfonic acid, 0.1 % β-mercaptoethanol, 10 % FBS,
and 20% sL929-conditioned medium containing macrophage
colony-stimulating factor (M-CSF). After 7–10 days in cul-
ture, nonadherent cells were removed and adherent cells har-
vested for assays to examine the functional capabilities of
macrophages under different external stimulation conditions,
as described previously [20]. To promote polarization into M1
or M2 macrophages, BMDMs were treated with LPS
(100 ng/ml; Sigma-Aldrich, St. Louis, MO, USA) plus
IFN-γ (20 ng/ml; Peprotech, Rocky Hill, NJ, USA) or IL-4
(20 ng/ml; Peprotech) for 24 h, respectively. Supernatants
from stimulated macrophages were collected for further anal-
ysis. The control group received no treatment except a change
of medium.
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Primary Microglial Cultures
Microglial cells were isolated from neonatal (1–3-day-old)
C57BL/6 mice and PD-1 KO mice, as described previously
[21]. Briefly, the cerebral cortex was dissected and the menin-
ges carefully removed under a microscope. The cerebral cor-
tical tissue was then minced and digested with 0.125 % tryp-
sin. Cells were plated onto tissue culture T-75 flasks and in
Dulbecco’s modified Eagle medium (DMEM)/F12 (Gibco)
containing 10 % FBS and 2 mM L-glutamine. After 14–
18 days in culture, microglial cells were collected by shaking
the flasks at 220 rpm/min for 3–6 h. Immunostaining for
CD11b and ionized calcium-binding adapter molecule 1
(Iba1) confirmed the purity of the culture as >95%microglial.
Microglial cells were cultured in 6-well culture-plates at a
density of 1×106 cells per well. To promote polarization into
the M1 or M2 phenotype, microglia were treated with LPS
(100 ng/ml) plus IFN-γ (20 ng/ml) or IL-4 (20 ng/ml), respec-
tively, for 24 h. The control group received no treatment
except for a change of medium.
Quantitative Reverse Transcription Polymerase Chain
Reaction
Total RNAwas prepared frommacrophages/microglia or an 8-
mm length of spinal cord tissue from the injured site by lysis in
TRIzol (Invitrogen, Carlsbad, CA, USA) following the man-
ufacturer’s instructions. After total RNA was reverse tran-
scribed, the complementary DNA was used to amplify Pd1,
Pdl1, inos, Arg1, Cd206, Il1b, Il4, Il10, Il12, Tnfa, Tgfb, and
Actb. Reverse transcription polymerase chain reaction (PCR)
was performed using the SYBR Premix Ex Taq™IIkit
(DRR036A; TaKaRa, Otsu, Japan) and Bio-RadCFX 96
Real-time PCR system (Bio-Rad Laboratories, Hercules,
CA, USA), with β-actin used as a reference control. The
primers used in the PCRs are shown in Table 1.
Western Blotting
Ice-cold lysis buffer (200 μl; 50 mM Tris-HCl, 5 mM ethyl-
enediaminetetraacetic acid, 150 mM NaCl, 0.5 %
deoxysodium cholate, 0.1 % sodium dodecyl sulfate, 1 mM
dithiothreitol, pH 8.0) containing the protease inhibitors
aprotinin (20 μg/ml), phenyl methanesulfonyl fluoride
(1 mM), sodium fluoride (5 mM), and sodium orthovanadate
(1 mM) was added to each well. The spinal cord tissue
samples were collected and then homogenized (10 μl/μg).
The homogenates were centrifuged at 15,000g for 10 min at
4 °C and the supernatants collected. Protein concentration was
determined using the Bradford method. Samples were boiled
for 10 min and proteins separated on 8–15 % sodium dodecyl
sulfate polyacrylamide gels via electrophoresis (110 V) and
transferred (20 V, overnight) onto polyvinylidene fluoride
membranes (Millipore, Billerica, MA, USA), which were then
blocked with 5 % nonfat milk for 1 h at room temperature.
Membranes were incubated (16–24 h at 4 °C) with the prima-
ry antibody for iNOS (1:1000; Abcam, Cambridge, UK),
Arg1 (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), STAT1/p-STAT1 (both 1:1000; Cell Signaling, Dan-
vers, MA, USA), STAT6/p-STAT6 (both 1:1000, Santa Cruz
Biotechnology), or nuclear factor-kappa B (NF-κB) (P65)/p-
P65 (both 1:1000; Cell Signaling). Membranes were then
washed with Tris-buffered saline containing Tween 20 and
incubated with the secondary antibody conjugated with horse-
radish peroxidase (1:8000; Jackson ImmunoResearch, West
Rove, PA, USA) for 2 h at room temperature. Bands were
visualized with Electro Chemical Luminescence (ECL) solu-
tion and the Bio-Rad Image Lab system. The densities of
specific bands were measured with Image J software (NIH,
Bethesda, MD, USA).
Enzyme-Linked Immunosorbent Assay
Macrophage/microglial culture supernatants were collected
after treatment to measure the secreted inflammatory media-
tors using IL-12, IL-10, TNF-α, and IFN-γ enzyme-linked
immunosorbent assay (ELISA) kits (R&D Systems, Minne-
apolis, MN, USA), according to their respective protocols.
Flow Cytometry
Microglial cells (1×106) were first incubated in rat serum
and antimouse CD16/CD32 (1:50; BD Pharmingen, San
Jose, CA, USA). Fluorescein isothiocyanate (FITC)-conju-
gated rat antimouse PD-1 (1:100; eBioscience, San Diego,
CA, USA) and phycoerythrin (PE)-conjugated rat
antimouse PD-L1 (1:100; eBioscience) or isotype-
matched antibodies (Sigma-Aldrich) were then added for
30 min at 4 °C. Cells were washed with fluorescence-
activated cell sorting solution [phosphate-buffered saline
(PBS) containing 1 % fetal bovine serum and 0.05 %
NaN3] and then resuspended in 200 μl fluorescence-
activated cell sorting solution. For cytoplasmic staining,
4 μl BD golgistop solution (BD Pharmingen) was added
for every 6 ml of cell culture and thoroughly mixed during
the last 6 h of stimulation. Intracellular cytokines were
assayed following the recommended protocols (BD
Cytofix/Cytoperm Plus Fixation/Permeabilization Kit; BD
Pharmingen). FITC-conjugated antimouse IFN-γ (1:100;
eBioscience) and PE-conjugated antimouse Il-4 (1:100;
eBioscience) were used for this assay. Flow cytometry
analysis was performed using the Millipore flow cytometer
(Guawa 6HT). The data were analyzed using FlowJo soft-
ware v. 7.6.2 (TreeStar, Ashland, OR, USA).
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Phagocytosis Assay
Carboxylate-modified red fluorescent latex beads (2 μm di-
ameter; 4 μl of 2.5 % latex bead solution; Sigma-Aldrich)
were opsonized in 10 % FBS with DMEM or DMEM/DF12
(6 ml) for 60 min at 37 °C. Subsequently, cells were washed
twice with ice-cold PBS to remove uningested particles, and
fixed with 4 % paraformaldehyde. The fluorescence of mac-
rophages or microglia were measured by flow cytometry.
Results were presented as a percentage of the phagocytic cell
population (number of cells that ingest at least 1 bead/total
number of cells×100 %) and phagocytosis index (average
number of ingested beads per cell = number of ingested
beads/total number of cells).
Immunofluorescence
BMDMs and microglial cells were fixed with 4 % parafor-
maldehyde in 0.1 M phosphate buffer (pH 7.4) for 15 min,
then blocked for 1 h with 1 % bovine serum albumin contain-
ing 0.3 % Triton X-100, followed by incubation (overnight at
4 °C) with the following primary antibodies: goat antimouse
PD-L1 (1:100; R&D Systems), rat antimouse PD-1 (1:100;
AbD Serotec, Oxford, UK), rabbit antimouse Iba1 (1:1000;
Wako, Osaka, Japan), After cells were washed with PBS, they
were incubated (for 2 h at room temperature) with their
respective secondary antibody: Dylight (Dy)488- and
Dy594-conjugated secondary antibodies (all 1:1000; Jackson
ImmunoResearch, West Grove, PA). Images were acquired
using FV 1000 confocal microscope (Olympus, Tokyo,
Japan).
Immunohistochemistry
Fourteen days after SCI, animals were perfused through
the left cardioventricle with 10 ml of physiological saline
followed by 40 ml of 4 % paraformaldehyde in 0.1 M
phosphate buffer. Spinal cord tissues were postfixed for
4–6 h and immersed in 25 % sucrose solution for 24–
48 h at 4 °C until they sank. Sections were cut (12 μm
thickness) with a cryostat and thaw-mounted onto
gelatinized slides followed by blocking with 1 % bovine
serum albumin containing 0.3 % Triton X-100 for 1 h.
Sections were then incubated (overnight at 4 °C) with
the following primary antibodies: goat antimouse PD-L1
(1:100; R&D Systems), rat antimouse PD-1 (1:100; AbD
Serotec), rabbit antimouse Iba1 (1:1000; Wako), goat
antimouse Arg1 (1:100; Santa Cruz Biotechnology), rab-
bit antimouse iNOS (1:200; Abcam), rat antimouse F4/80
(1:100; AbD Serotec). The next steps for single, double,
and triple staining were performed using standard immu-
nocytochemical methods. The sections were then incu-
bated (for 2 h at room temperature) with the respective
secondary antibodies and the following direct fluorescent
antibodies: FITC-conjugated rat antimouse PD-1 (1:100;
eBioscience), PE-conjugated rat antimouse PD-L1
(1:100; eBioscience), allophycocyanin-conjugated rat
antimouse F4/80 (1:100; eBioscience). Dy488-, Dy594-,
and Dy649-conjugated secondary antibodies (all 1:1000;
Jackson ImmunoResearch) were used to visualize the
primary antibodies. Images were acquired with a FV
1000 confocal microscope (Olympus).
Open Field Locomotion
The Basso Mouse Scale (BMS) score was used to assess
locomotor behavior of mice after SCI. The animals were
placed in an open field (80×130×30 cm) free of any tactile
stimulation, and the test was performed according the rules of
the BMS score [22]. To assess their performance using the
BMS score, each animal was observed by two evaluators
(blinded to the treatment) for 4 min.
Table 1 Polymerase chain reac-













PD-1 Deficiency in Spinal Cord Injury 639
Statistical Analysis
All data are presented as the mean±standard error of the mean
(unless otherwise stated). Independent samples t tests were
used to compare the two groups separately. Analysis of vari-
ance followed by the Tukey–Kramer test was used for multi-
ple comparisons. Statistical analysis was performed with the
OriginPro 7.0 program. Significance was reached at values of
p<0.05 or p<0.001.
Results
PD-1 is Upregulated in Macrophages/Microglia After SCI,
and PD-1 Deficiency Causes Macrophages/Microglia
to Polarize to M1-type Cells in Injured Spinal Cords in Mice
Most studies on the role of PD-1 in the central nervous system
(CNS) have focused on experimental autoimmune encepha-
lomyelitis (EAE), which is a prototypical autoimmune disease
of the CNS [23–25]. However, there are almost no reports on
the function of PD-1 in SCI that include macrophages/
microglia as the major inflammatory cells that determine
functional recovery [1, 2]. We first performed quantitative
reverse transcription PCR to quantify the expression of Pd1
mRNA at different time points after SCI. Pd1 mRNA in-
creased in 2 phases 42 days after SCI (Fig. 1a). Pd1 mRNA
increased 5-fold (5.11±0.75) compared with control mice
7 days after SCI. Pd1mRNA in macrophages increased more
than 13-fold (13.07±1.58) from 14 and 42 days after injury
(Fig. 1a). The highest fold increase (17.80±1.78) was ob-
served 28 days after SCI. We also quantified the mRNA levels
of Pdl1. Pdl1mRNA increased approximately 1-fold 14 days
after injury (Fig. 1b). Immunohistochemistry (IHC) revealed
enhanced expression of both PD-1 (Fig. 1c) and PD-L1
(Fig. 1d) in macrophages/microglia localized in the lesion
areas after SCI. However, neither PD-1 nor PD-L1 was de-
tected in normal spinal cord sections (data not shown). Fur-
thermore, the presence of PD-L1, but not PD-1, was observed
in astrocytes around the lesion sites after SCI (Supplementary
Fig. S1). These results suggest that both PD-1 and PD-L1 are
upregulated after SCI.
To detect whether PD-1 and PD-L1 molecules are also
expressed in polarized macrophages/microglia, triple IHC
was used to detect PD-1 and PD-L1 in M1 (iNOS+; Fig 1e, g)
orM2 (Arg1+) cells (Fig. 1f, h). PD-1 and PD-L1were found to
be present in M1 and M2 cells in injured spinal cord at 14 days
postinjury (dpi) in WT mice (Fig. 1e–h).
Next, we used a severe crush model of SCI to determine
locomotor recovery in both PD-1-KO and WT mice. Al-
though PD-1-KO mice had low BMS scores 1 week after
injury, they were not significantly different compared with
WT mice (Fig. 1i). In contrast, PD-1-KO mice showed poor
locomotor recovery 2 and 3 weeks after SCI compared with
WT mice, indicating that PD-1 deficiency delays locomotor
recovery after SCI.
Polarized macrophages/microglia determine locomotor re-
covery after SCI [3, 7]. To assess whether PD-1 deficiency
induces the polarization of macrophages and microglia
in vivo, we used antibodies against specific M1 and M2
markers to detect these cells in spinal cord sections by IHC
after SCI in both WT and PD-1-KO mice. At 14 dpi, the
number of iNOS-positive macrophages/microglia (M1 cells)
was higher in PD-1 KO than inWTmice, whereas the number
of Arg1-positive macrophages/microglia (M2 cells) was lower
in PD-1 KO mice than in WT mice (Fig. 1j). These results
suggest that, after SCI, PD-1 deficiency causes macrophages/
microglia to polarize to M1-type cells.
PD-1 is Upregulated in Cultured Macrophages and Microglia
Under Polarized Stimulation
To evaluate whether expression of PD-1 and PD-L1 is regu-
lated by inflammatory cytokines in macrophages and microg-
lia, we stimulated cultured BMDMs and primary microglia
with LPS + IFN-γ or IL-4, which are the classical stimuli used
to polarize macrophages into the M1 or M2 phenotype, re-
spectively [4]. The level of PD-1 was higher in BMDMs
stimulated with LPS + IFN-γ compared with those stimulated
with IL-4 (Fig. 2a). PD-1 was weakly present in control
BMDMs (Fig. 2a). PD-L1 was also upregulated in BMDMs
under LPS + IFN-γ or IL-4 stimulation. Similarly to PD-1, the
presence of PD-L1 was higher in BMDMs stimulated with
LPS + IFN-γ (Fig. 2b). These results suggest that the expres-
sion levels of PD-1 and PD-L1 are increased in both M1 and
M2 macrophages.
The results from IHC (data not shown) and flow cytometry
analysis revealed an increased expression of both PD-1 and
PD-L1 in primary microglia stimulated with LPS + IFN-γ or
IL-4 (Fig. 2c–e). PD-1 expression was induced in approxi-
mately 10.3±0.51 % and 3.4±0.25 % of microglial cells with
a 24-h treatment of LPS + IFN-γ and IL-4 (Fig. 2c, d), re-
spectively. The expression of PD-L1 was higher than that of
PD-1. In the LPS + IFN-γ group, 88.8±2.80 % of microglia
expressed PD-L1 compared with 66.5±2.70 % in the IL-4
group (Fig. 2c, e). These results show that the expression PD-
1 and PD-L1 is induced in macrophages and microglia under
polarized stimulation, suggesting that PD-1 may play a role in
the regulation of the polarization of macrophages and
microglia.
PD-1 Deficiency Improved M1 Polarization of Cultured
Macrophages
iNOS and Arg1/mannose receptor (CD206) were used as
characteristic markers for M1 and M2 polarization,
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Fig. 1 Expression of programmed death-1 (PD-1) in macrophages/mi-
croglia after spinal cord injury (SCI) in mice. Quantitative reverse tran-
scription polymerase chain reaction at each timepoint after SCI for (a)
Pd1 (n=3 mice in each group) and (b) Pdl1 (n=3 mice in each group).
Immunohistochemistry (IHC) in macrophages/microglia 14 days
postinjury (dpi) in wild-type (WT) mice for (c) PD-1, (d) it’s ligand,
PD-L1, and (e) PD-1 in M1 cells [inducible nitric oxide synthase
(iNOS)+]; (f) PD-1 in M2 cells [arginase 1 (Arg1+)]; (g) PD-L1 in M1
cells (iNOS+); and (h) PD-L1 in M2 cells (Arg1+). The injury epicenter in
(c) and (d) are denoted with an asterisk. (i) Locomotor recovery evaluated
by the Basso Mouse Scale (BMS) score acquired at different timepoints
after SCI inWTand PD-1–/–mice (n=8mice). (j) IHC for iNOS andArg1
in macrophages/microglia at 14 dpi. (a, b) ###p<0.001 versus control,
***p<0.001 versus the previous timepoint. (i) *p<0.05 versusWTmice.
Scale bar=(c–h) 100 μm and (j) 200 μm. KO = knockout; Iba1 = ionized
calcium-binding adapter molecule-1; DAPI=4’,6-diamidino-2-
phenylindole
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respectively [7, 26]. In BMDMs from PD-1-KO mice
and those stimulated with LPS + IFN-γ or IL-4, the
levels of inos mRNA were significantly increased com-
pared with control BMDMs (Fig. 3a). However, the
mRNA levels of Arg1 and Cd206 were significantly
reduced in IL-4-stimulated BMDMs (Fig. 3b, c). Protein
levels of iNOS in PD-1-deficient BMDMs were also
upregulated in polarized stimulations (Fig. 3d, e), while
Arg1 in cytokine-stimulated BMDMs did not differ from
those of control (Fig. 3d, f), which may have been
caused by the treatment of these cells with M-CSF dur-
ing BMDM differentiation. M-CSF can induce the ex-
pression of part of the M2 transcriptome, suggesting that
a default shift towards the M2 phenotype may occur
under homeostatic conditions [6].
We also measured the levels of the proinflammatory
cytokines (M1 polarization) IL-12 (Fig. 3g), TNF-α
(Fig . 3h) , and IFN-γ (Fig . 3i) , and the ant i -
inflammatory cytokines (M2 polarization) IL-10
(Fig. 3j) and IL-4 (Fig. 3k) by ELISA and flow cytom-
etry. ELISA assays showed that macrophages from PD-1
KO mice produced higher levels of proinflammatory
cytokines than WT mice (Fig. 3g–i); however, the levels
of anti- inflammatory cytokines were decreased
(Fig. 3j, k). The levels of IFN-γ and IL-4 in the IFN-γ
+ LPS- and IL-4-treated groups were not measured be-
cause both cytokines were added to the culture medium
to polarize BMDMs. Instead, we quantified the amount
of cytoplasmic IFN-γ and IL-4 in these groups via im-
munostaining with the corresponding antibodies. We
then analyzed them by flow cytometry (Fig. 3l–o). As
expected, macrophages from PD-1 KO mice expressed more
IFN-γ in the LPS + IFN-γ -treated group (Fig. 3l, m);
however, IL-4 was reduced in the IL-4 group (Fig. 3n, o).
These results suggest that PD-1 deficiency shifts the mac-
rophage population towards M1 polarization instead of M2
polarization.
PD-1 Deficiency Improves the M1 Polarization of Cultured
Microglia
We also examined the effects of PD-1 on the polarization
of primary microglia isolated from PD-1 KO and WT
mice. Microglial cells from PD-1-KO mice exhibited an
enhanced M1 response when treated with LPS + IFN-γ,
as shown by an increase in the protein expression of iNOS
compared with controls (Fig. 4a, b). In contrast, Arg1 was
reduced in the IL-4 group, indicating an attenuated M2
response (Fig. 4a, c). Analysis of mRNA expression
showed that in microglia from PD-1-KO mice, the expres-
sion levels of Il12 (Fig. 4d), Il1b (Fig. 4e), and Tnfa
(Fig. 4f) under LPS + IFN-γ stimulation were higher than
in WT mice (Fig. 4d–f); however, the expression levels of
Il4 (Fig. 4g), Il10 (Fig. 4h), and Tgfb (Fig. 4i) were
suppressed. These results indicate that, in a similar man-
ner to macrophages, PD-1 deficiency shifts microglial
polarization towards the M1 phenotype instead of the
M2 phenotype.
PD-1 Deficiency Influences the Polarization of Cultured
Macrophages/Microglia via STAT1 and STAT6
IFN-γ promotes the M1 phenotype in macrophages main-
ly through the Janus kinase (JAK)-STAT1 signaling path-
way, whereas IL-4 promotes the M2 phenotype in macro-
phages mainly through the JAK-STAT6 signaling pathway
[3, 27]. Because STAT1 and STAT6 have a reciprocal
inhibitory relationship in macrophage polarization [3,
27], our next aim was to determine if PD-1 regulates
M1 and M2 polarization through the STAT1 and STAT6
pathways, respectively. Levels of phosphorylated (p)-
STAT1 were significantly increased in BMDMs from
PD-1-KO with or without polarized stimulation compared
with the levels in WT BMDMs (Fig. 5a, b). In contrast,
the level of p-STAT6 was significantly decreased in PD-1-
KO BMDMs under IL-4 stimulation as compared with
WT BMDMs (Fig. 5a, d). In microglia isolated from
PD-1-KO mice, an enhanced level of p-STAT1 was found
only in the LPS + IFN-γ-treated group (Fig. 5f, g) com-
pared with WT microglia. No change in the level of p-
STAT1 was observed in PD-1-KO microglia stimulated
with IL-4 (Fig. 5f, g). However, p-STAT6 was significant-
ly decreased in this group (Fig. 5f, i). Our results indicate
that PD-1 deficiency promotes M1 rather than M2 polar-
ization of macrophages/microglia by enhancing the ex-
pression of p-STAT1 and downregulating p-STAT6.
PD-1 Deficiency Influences the Polarization
of Macrophages/Microglia via STAT1 and NF-κB
Under In Vivo Conditions
To further confirm that a deficiency in PD-1 induces the
polarization of macrophages/microglia, we quantified the
protein expression levels of iNOS and Arg1 in samples
extracted from injured spinal cord tissues at 14 and 21
dpi. Consistent with the IHC results shown in Fig. 1, the
level of iNOS was significantly higher and Arg1 was
lower in PD-1-KO mice compared with the control group.
This difference was observed at 14 dpi (Fig. 6a–c).
STAT1 and NF-κB are two important transcription factors
that regulate the expression of genes characteristic of the
M1 phenotype [3, 27]. PD-1 deficiency enhanced the
phosphorylation of STAT1 (Fig. 6a, d) and NF-κB
(Fig. 6a, f) at 14 dpi in the lesion site, indicating that
PD-1 regulates macrophage/microglial plasticity and po-
larization via different signaling pathways. Similar results
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were obtained in samples extracted from injured spinal
cord tissues at 21 dpi (Fig. 6h–n).
A Deficiency in PD-1 has Divergent Roles in Macrophages
and Microglia in Terms of Phagocytosis
Phagocytosis is the key mechanism of innate immunity,
involving the internalization of diverse particulate targets
by macrophages, dendritic cells, and other myeloid
phagocytes [28]. Macrophages contribute to the balance
between antigen availability and clearance through phago-
cytosis and subsequent degradation [6]. To investigate the
role of PD-1 in the regulation of macrophage/microglial
phagocytosis under different polarized phenotypes,
carboxylate-modified red fluorescent latex beads were
incubated with either polarized macrophages or microglia
and flow cytometry was then performed to estimate the
number of latex beads ingested by each cell (Fig. 7a, b).
The percentage of phagocytic cells and the phagocytosis
index showed that BMDMs stimulated with IL-4 from the
WT group phagocytized more latex beads than those cells
from the control group and the LPS + IFN-γ group
(Fig. 7c, g, h). Compared with WT BMDMs, PD-1-KO
decreased the phagocytic ability of BMDMs with or
Fig. 2 Quantification of programmed death-1 (PD-1) and it’s ligand, PD-
L1, in cultured macrophages and microglia under polarized stimulation.
The presence of PD-1 (a) and PD-L1 (b) in cultured macrophages
respectively, under lipopolysaccharide (LPS) + interferon-gamma
(IFN-γ) or interleukin (IL)-4 stimulation. (c) Flow cytometry of PD-1
and PD-L1 in cultured microglia under LPS + IFN-γ or IL-4 stimulation.
Percentage of (d) PD-1- and (e) PD-L1-positive cells in polarized mi-
croglia. Scale bar=100 μm. n=3 mice in each group. ***p<0.001. Con =
control; Iba1 = ionized calcium-binding adapter molecule-1; DAPI=4’,6-
diamidino-2-phenylindole
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without polarized stimulation (Fig. 7d–h), while PD-1-
KO BMDMs stimulated with IL-4 increased phagocytic
ability compared with the control and the LPS + IFN-γ
groups (Fig. 7g, h). These results suggest that in WT
BMDMs, M2 macrophages possess a better phagocytic
ability than M1 macrophages, and that a PD-1 deficiency
decreased the phagocytic ability of BMDMs in both the
M1 and M2 phenotypes.
Next we studied the effect of PD-1 deficiency on
microglial phagocytosis. Interestingly, the characteristics
of phagocytosis in microglia were quite different from
those in BMDMs. In contrast to BMDMs, LPS + IFN-γ
treatment of WT microglia resulted in the highest
phagocytic ability compared with the control and IL-4
stimulation groups (Fig. 7i, m, n). However, regardless
of the cytokine stimulus used, treatment of PD-1 KO
microglia resulted in a better phagocytic ability com-
pared with WT microglia (Fig. 7j–n). These results sug-
gest that in WT-derived microglia, M1-polarized
microglial cells possess a better phagocytic ability than
M2 cells, and that a PD-1 deficiency enhances phagocy-
tosis by microglia in both the M1 and M2 phenotypes.
In summary, both WT macrophages and microglia were
polarized to the M1 or M2 phenotype under LPS + IFN-γ or
IL-4 stimulation, respectively. However, their phagocytic abil-
ities were quite different. M2 macrophages had a better






from wild-type (WT) and PD-1-




interleukin (IL)-4 for 24 h
followed by quantitative reverse
transcription polymerase chain
reaction for (a) inos, (b) Arg1, and
(c) Cd206, and Western blotting
(d) for inducible nitric oxide
synthase (iNOS) and arginase 1
(Arg1). Densitometric analysis of
protein bands for (e) iNOS and (f)
Arg1 normalized to β-actin.
Enzyme-linked immunosorbent
assays for the proinflammatory
cytokines: (g) IL-12, (h) tumor
necrosis factor-alpha (TNF-α),
and (i) IFN-γ, and the anti-
inflammatory cytokines: (j) IL-10
and (k) IL-4. Cytoplasmic (l)
IFN-γ and (n) IL-4 in BMDMs
measured by flow cytometry for
(m) IFN-γ and (o) IL-4,
respectively. n=3 mice in each
group. *p<0.05, **p<0.01,
***p<0.001. Con=control
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phagocytic ability than M1 macrophages, whereas M1
microglial cells had a better phagocytic ability than M2 mi-
croglia. In general, a deficiency in PD-1 decreased the phago-
cytic ability of macrophages and increased microglial phago-
cytosis, but phagocytic tendencies between WT polarized
macrophages and microglia did not change.
Discussion
PD-1 is a critical co-inhibitory receptor; its gene was first
reported to be upregulated in a T-cell hybridoma undergoing
cell death [29]. PD-1 and its ligands, PD-L1 and PD-L2,
deliver inhibitory signals that regulate the balance between
T-cell activation, tolerance, and immunopathology [11].
Most studies on the role of PD-1 in the CNS are focused
on EAE [23–25]. A PD-1 deficiency increases the severity
of EAE owing to the loss of its inhibitory effect on
autoreactive T lymphocytes [23, 24]. Recently, several stud-
ies have shown the inducible expression of PD-1 in
monocytes/macrophages and dendritic cells [13, 15,
30–32]. However, reports on PD-1 in macrophages/
microglia to determine a functional recovery from SCI are
scarce [1, 2]. The results of this study show that PD1 is
upregulated following SCI and the PD-1 protein is expressed
mainly on macrophages/microglia. However, some PD-1-
positive cells negative for Iba-1 were found at the lesion
site of the injured spinal cord, suggesting that these cells,
which were not identified as neuronal cells (data not shown),
are other blood-derived cells, such as lymphocytes [1, 8].
PD-L1 is the most important ligand of PD-1 and is widely
expressed in neurons, astrocytes, microglia, and endothelial
cells in CNS inflammatory diseases and models such as
EAE and multiple sclerosis [24, 33]. Our findings show a
Fig. 4 Deficiency of
programmed death-1 (PD-1)
deficiency enhances M1
polarization of cultured microglia.
(a) Western immunoblot for
inducible nitric oxide synthase
(iNOS; M1 phenotype) and
arginase 1 (Arg1) (M2
phenotype) in primary microglial
cells isolated from wild-type
(WT) and PD-1-knockout (KO)
mice and stimulated with
lipopolysaccharide (LPS) +
interferon (IFN)-γ or interleukin
(IL)-4 for 24 h. Densitometric
analysis of (b) iNOS and (c) Arg1
normalized to β-actin.
Quantitative reverse transcription
polymerase chain reaction of
proinflammatory cytokines (d)
Il12, (e) Il1b, and (f) Tnfa; anti-
inflammatory cytokines (g) Il4,
(h) Il10, and (i) Tgfb. n=3 mice in
each group. *p<0.05, **p<0.01,
***p<0.001. Con = control; ns =
not significant
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Fig. 5 Deficiency in programmed death-1 (PD-1) deficiency influences
the polarization of macrophages and microglia via signal transducer and
activator of transcription (STAT)1 and STAT6. (a) Western immunoblot
for phosphorylated (p)-STAT1, STAT1, p-STAT6, and STAT6 in macro-
phages stimulated with lipopolysaccharide (LPS) + interferon (IFN)-γ or
interleukin (IL)-4 for 24 h. Band intensities of (b) p-STAT1, (c) STAT1,
(d) p-STAT6, and (e) STAT6 normalized to β-actin. (f) Western immu-
noblot for p-STAT1, STAT1, p-STAT6, and STAT6 in microglial cells
stimulated with LPS + IFN-γ or IL-4 for 24 h. Densitometric analysis for
(g) p-STAT1, (h) STAT1, (i) p-STAT6, and (j) STAT6 normalized to β-
actin. n=3 mice in each group. *p<0.05, **p<0.01. Con = control; ns =
not significant
Fig. 6 Mechanism of programmed death-1 (PD-1) deficiency influences
the polarization of macrophages/microglia in vivo after spinal cord injury.
(a) Western immunoblot of inducible nitric oxide synthase (iNOS), argi-
nase 1 (Arg1), phosphorylated signal transducer and activator of tran-
scription (p-STAT1), signal transducer and activator of transcription
(STAT1), phosphorylated nuclear factor kappa-B (p-NF-κB), and nuclear
factor kappa-B (NF-κB) in wild-type (WT) (n=3) and PD-1-knockout
(KO) mice (n=4) 14 days postinjury (dpi). Densitometric analysis for (b)
iNOS, (c) Arg1, (d) p-STAT1, (e) STAT1, (f) p-NF-κB, and (g) NF-κB
relative to β-actin. (h) Western immunoblot of iNOS, Arg1, p-STAT1,
STAT1, p-NF-κB, andNF-κB inWTmice (n=3) and PD-1-KOmice (n=
4) 21 dpi. Densitometric analysis for (i) iNOS, (j) Arg1, (k) p-STAT1, (l)
STAT1, (m) p-NF-κB, and (n) NF-κB relative to β-actin. *p<0.05,
**p<0.01, ***p<0.001. ns=not significant
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high level of expression of PD-L1 in macrophages/microglia
and astrocytes at the lesion site of the spinal cord. In
addition to its role in the CNS, PD-1 in macrophages has
been found to regulate negatively cytokine secretion, cell
differentiation, and microbial clearance [13, 15, 16, 30, 32].
Therefore, PD-1 may provide a negative feedback signal to
regulate precisely activation, cytokine secretion, and differ-
entiation of macrophages/microglia after SCI.
Fig. 7 A deficiency in programmed death-1 (PD-1) deficiency promotes
opposing phagocytic effects in macrophages and microglia. (a) Repre-
sentative image under light microscopy showing the morphology of
macrophages that did not phagocytize any beads (P0), and phagocytized
1 bead (P1), 2 beads (P2), or numerous beads (>P2). (b) Representative
diagram showing macrophages with phagocytized beads by flow cyto-
metric analysis. (c) Phagocytosis of wild-type (WT) macrophages under
polarized stimulation analyzed by flow cytometry. Phagocytosis of WT
and PD-1-knockout (KO) macrophages with (d) no stimulus, (e) lipo-
polysaccharide (LPS) + interferon-gamma (IFN-γ), or (f) interleukin
(IL)-4. (g) The percentage of phagocytic cells calculated in WT and
PD-1-KO macrophages. (h) The phagocytosis index calculated in WT
and PD-1-KO macrophages. (i) Phagocytosis of WT microglia under
polarized stimulation analyzed by flow cytometry. Phagocytosis of WT
and PD-1-KOmicroglia with (j) no stimulus, (k) LPS + IFN-γ, or (l) IL-4.
(m) The percentage of phagocytic cells in WT and PD-1-KO microglia.
(n) The phagocytosis index calculated for WT and PD-1-KO microglia.
n=3 mice in each group. #p<0.05, ##p<0.01 versus WT, *p<0.05,
**p<0.01 versus WT and PD-1-KO. Con = control
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Macrophages respond to environmental cues (e.g., micro-
bial products, damaged cells, activated lymphocytes),
resulting in two opposing functional phenotypes, defined as
M1 (the classical proinflammatory macrophage) and M2 (the
alternatively activated anti-inflammatory macrophage) [3, 27,
34]. The findings of this study show high expression of both
PD-1 and PD-L1 in the treatment of cultured BMDMs and
microglial cells with LPS + IFN-γ (for M1 stimulation) and
IL-4 (for M2 stimulation), respectively. However, expression
of PD-1 was observed in control BMDMs. These cells were
cultured with M-CSF, which has been shown to induce the
expression of a part of the M2 transcriptome, suggesting that a
default shift towards the M2 phenotype may occur under
homeostatic conditions [6, 26].
SCI elicits a robust and persistent inflammatory response
[1]. Proinflammatory cytokines, reactive oxygen species, me-
talloproteinases, and danger-associated molecular patterns
(such as high-mobility group box 1 protein, histones, and
adenosine triphosphate), are released during the early stage
of SCI [1, 35, 36]. Under this inflammatory environment,
most macrophages/microglia exhibit the M1 phenotype, and
the M2 phenotype is displayed transiently or in a small num-
ber of cells [7]. M1macrophages/microglia secrete proinflam-
matory cytokines and upregulate iNOS and reactive oxygen
species, which are both neurotoxic and prevent axonal regen-
eration [2, 7, 27, 37]. The environment of the spinal cord in the
later stages of SCI switches macrophages/microglia to the M2
phenotype, thereby releasing trophic factors (e.g., insulin-like
growth factor, brain derived neurotrophic factor, and nerve
growth factor), and anti-inflammatory cytokines (e.g., IL-4,
IL-10, and TGF-β), inducing neuroprotection and promoting
axonal regeneration [1, 34]. Whether the mechanism underly-
ing these switches involves the recruitment of circulating
precursors or the re-education of cells in situ remains unclear
[27]. In this study, LPS + IFN-γ treatment of cultured
macrophages/microglia from PD-1 deficient mice promoted
M1 polarization of these cells, and increased their expression
of iNOS and proinflammatory cytokines. In contrast, IL-4
reduced M2 polarization of these cells from PD-1 deficient
mice by decreasing their expression of Arg1 and CD206. We
also showed that, under in vivo conditions, PD-1 deficiency
delayed the switch from the M1 to M2 phenotype at the
injured site and exacerbated locomotor recovery after SCI.
At the early stages of SCI in WT mice, infiltrating macro-
phages and resident microglia are polarized towards the M1
phenotype with induced expression of PD-1 in the proinflam-
matory milieu [1, 35, 36]. After SCI, macrophages/microglia
highly expressing PD-1 recruit PD-L1 from other
macrophages/microglia or astrocytes at the lesion site to pro-
vide a negative feedback signal [1, 35, 36]. This effect de-
creases the high expression of iNOS and proinflammatory
cytokines, and also skews the polarization of macrophages/
microglia towards the M2 phenotype [23, 13, 16, 32].
Canonical IFN regulatory factor/STAT signaling pathways
activated by IFN and Toll-like receptor (TLR) signaling pro-
mote the formation of M1 macrophages via STAT1 activation
[3, 27]. In contrast, IL-4 and IL-13 promote theM2 phenotype
via STAT6 activation [3, 27]. Blocking IFN-γ- and IL-4-
mediated STAT1 activation for T helper cell 1 polarization
and STAT6 activation for T helper cell 2 polarization, respec-
tively, has been well established [38]. A similar mechanism
may underlie the exclusivity of M1 and M2 phenotypes in
macrophages [3]. Upon activation of PD-1 by PD-L1, SHP-2
or SHP-1/SHP-2 is recruited to bind to its cytoplasmic domain
ITIM and immunoreceptor tyrosine-based switch motif [11].
SHP-2 has been shown to inhibit IFN-γ stimulation of the
JAK-STAT signaling pathway [39]. Electrophoretic mobility
shift assay and site-directed mutagenesis have shown that
IFN-sensitive responsive element, STAT1, and STAT2 are
primarily responsible for the constitutive expression of PD-
1, as well as for the IFN-α-mediated upregulation of PD-1
[14]. Furthermore, the cross-talk between PD-1 and the sup-
pressor of cytokine signaling-1 negatively regulates IL-12
expression by limiting STAT1 phosphorylation in
monocytes/macrophages from hepatitis C virus infection
[16, 32]. In this study, STAT1 phosphorylation was enhanced
in PD-1-KO macrophages/microglial cells treated with LPS +
IFN-γ, thus promoting the M1 phenotype. Decreased STAT6
phosphorylation of macrophages/microglial cells in the pres-
ence of IL-4 thereby polarized these cells toward the M2
phenotype. Increased levels of p-STAT1 in the injured spinal
cord were also confirmed in PD-1-KO mice after SCI. How-
ever, the cross-talk between PD-1 signaling and other signal-
ing pathways of cytokines, particularly IFN-γ and IL-4, is not
well understood, and needs to be further investigated in the
future.
LPS-activated macrophages are often classified as M1
macrophages owing to their increased levels of iNOS and
IL-12, and to the fact that TLR4 activation leads to NF-κB
activation [3, 27]. SHP-1 recruits the phosphorylation of ITIM
domains on inhibitory receptors. Studies byAn et al. [40] have
shown that SHP-1 negatively regulates TLR-mediated pro-
duction of proinflammatory cytokines by inhibiting the acti-
vation of NF-κB and mitogen-activated protein kinase. PD-1
has also been shown to inhibit LPS-mediated IL-12 produc-
tion and differentiation in murine macrophage RAW264.7
cells [13]. In this study, PD-1 deficiency increased NF-κB
activation after SCI. However, more studies are needed to
demonstrate that PD-1 directly regulates macrophage/
microglial polarization via NF-κB.
Another important aspect of the functional polarization of
macrophages is phagocytosis [28]. Previous studies have
shown that IL-4 and IL-13 enhance fluid-phase pinocytosis
and mannose receptor-mediated uptake by the activation of
phosphatidylinositol 3-kinase. In contrast, IL-10 or IFN-γ
decreased both fluid phase pinocytosis and mannose
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receptor-mediated uptake [41]. In this study, we found re-
markable differences between polarized macrophages and
microglial phagocytosis in culture. M2 macrophages derived
from WT mice displayed higher phagocytic ability than M1
macrophages. However, the M2 phenotype in WT microglial
cells displayed a lower phagocytic ability than M1 cells. This
is in agreement with a previous report, which showed that M2
macrophages phagocytize rituximab-opsonized leukemic tar-
gets more efficiently than M1 cells in culture [42]. Our find-
ings suggest that PD-1 deficiency causes a divergence of
phagocytosis in macrophages and microglia. In WT mice,
PD-1 deficiency decreased and increased the phagocytic abil-
ity of macrophages and microglia, respectively, and retained
the characteristic differences between the M1 and M2 pheno-
types. Microglial cells originate from the yolk sac and popu-
late the CNS early in development; moreover, these cells have
an extended life span with little turnover [43].Myeloid cells of
hematopoietic origin populate the perivascular space and have
a relatively rapid rate of repopulation. Under inflammatory
conditions and injury, hematogenous myeloid cells
(macrophages) access the CNS parenchyma. Currently, there
are no distinct lineage markers that distinguish microglia from
infiltrating macrophages [2]. In this study, PD-1 deficiency
promoted different regulatory roles in phagocytosis, suggest-
ing that significant heterogeneity exists between macrophages
and microglia. In this study, microglial cells were derived
from neonatal animals and macrophages were derived from
adult animals. Phagocytosis of pathogenic bacteria and char-
coal particles is impaired in aged microglia and macrophages
[44]. In view of these findings, the different ages of these
cultured cells in our study may have resulted in their differing
roles of phagocytosis in conditions of PD-1 deficiency. More
work is required to explore the exact mechanism.
Regulation of the immune response is a promising strategy
for successful SCI repair, and macrophages are considered
prospective candidates for cell therapy [45]. This study pro-
vides new insights into the modulatory mechanisms of
macrophage/microglial polarization by shedding light on
new therapies for SCI via PD-1-mediated polarization of
macrophages/microglia.
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